Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes
McGuire DK, Marx N, Mulvagh SL, et al.
N Engl J Med. Pub. online 29 Mar 2025.
Leggi
Breaking news
EMA qualifies first artificial intelligence tool to diagnose inflammatory liver disease (MASH) in biopsy samples
20/03/2025
Leggi
FDA: The safety and effectiveness of BAQSIMI for the treatment of severe hypoglycemia in patients with diabetes have been established in pediatric patients aged 1 year and older
19/03/2025
Leggi
Type 1 diabetes risk factors, risk prediction and presymptomatic detection: Evidence and guidance for screening
Bonifacio E, Ziegler AG
Diabetes Obes Metab. Pub. online 25 Mar 2025.
Leggi
Dapagliflozin in patients undergoing transcatheter aortic-valve implantation
Raposeiras-Roubin S, Amat-Santos IJ, Rossello X, et al.
N Engl J Med. Pub. online 29 Mar 2025.
Leggi
Semaglutide and nonarteritic anterior ischemic optic neuropathy risk among patients with diabetes
Hsu AY, Kuo HT, Wang YH, et al.
JAMA Ophthalmol. Pub. online 27 Mar 2025.
Leggi
Regulating islet stress responses through CD47 activation
Kale A, Azar M, Cheng V, et al.
Diabetologia. Pub. online 25 Mar 2025.
Leggi
Association of spontaneous abortion and lifestyle with diabetes mellitus in women: a cross-sectional study in UK Biobank
Liu S, Chen Y, Zhang A, et al.
BMC Pregnancy Childbirth. 2025;25(1):362.
Leggi
Development and validation of inpatient mortality prediction models for patients with hyperglycemic crisis using machine learning approaches
He R, Zhang K, Li H, Gu M
BMC Endocr Disord. 2025;25(1):86.
Leggi